Chondrosarcoma in Norway 1990–2013; an epidemiological and prognostic observational study of a complete national cohort-Reference-Cited by-同舟云学术

Chondrosarcoma in Norway 1990–2013; an epidemiological and prognostic observational study of a complete national cohort

Published:2019-01-11 Issue:3 Volume:58 Page:273-282
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Thorkildsen Joachim¹²,Taksdal Ingeborg³,Bjerkehagen Bodil⁴,Haugland Hans Kristian⁵⁶,Børge Johannesen Tom⁵,Viset Trond⁷,Norum Ole-Jacob¹,Bruland Øyvind²⁸,Zaikova Olga¹

Affiliation:

1. Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway;

2. Institute of Clinical Medicine, University of Oslo, Oslo, Norway;

3. Department of Radiology, Oslo University Hospital-Radiumhospital, Oslo, Norway;

4. Department of Pathology, Oslo University Hospital-Radiumhospital, Oslo, Norway;

5. Cancer Registry of Norway, Oslo, Norway;

6. Department of Pathology, Haukeland University Hospital, Bergen, Norway;

7. Department of Pathology, St Olav’s Hospital, University Hospital of Trondheim, Trondheim, Norway;

8. Department of Oncology, Oslo University Hospital-Radiumhospital, Oslo, Norway

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2018.1554260

Reference46 articles.

1. Survival and prognostic factors in chondrosarcoma

2. Clinical outcome of central conventional chondrosarcoma

3. Primary chondrosarcoma of long bones and limb girdles

4. Risk factors for survival and local control in chondrosarcoma of bone

5. Chondrosarcoma: A clinicopathologic and statistical analysis

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative prediction of histopathological grading in patients with chondrosarcoma using MRI-based radiomics with semantic features;BMC Medical Imaging;2024-07-11

2. C-Reactive Protein Pretreatment-Level Evaluation with Histopathological Correlation for Chondrosarcoma Prognosis Assessment—A 15-Year Retrospective Single-Center Study;Diagnostics;2024-07-04

3. Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma;Cells;2024-06-04

4. Trends in primary malignant bone cancer incidence and mortality in the United States, 2000–2017: A population-based study;Journal of Bone Oncology;2024-06

5. Diagnosis of chondrosarcoma in a noninvasive way using volatile organic compounds in exhaled breath: a pilot study;FUTURE ONCOL;2024